| 标题 |
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Liana K Billings; Stanley Hsia; Harold Bays; Beth Tidemann-Miller; Jessica O’Hagan; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |